Share this article on:

Semen Bacterial Concentrations and HIV-1 RNA Shedding Among HIV-1–Seropositive Kenyan Men

Korhonen, Christine J. MPH; Srinivasan, Sujatha PhD; Huang, Dandi BA; Ko, Daisy L. BS; Sanders, Eduard J. MD, MPH, PhD; Peshu, Norbert M. MBChB, MPH, DTCH; Krieger, John N. MD; Muller, Charles H. PhD; Coombs, Robert W. MD, PhD; Fredricks, David N. MD; Graham, Susan M. MD, MPH, PhD

JAIDS Journal of Acquired Immune Deficiency Syndromes: March 1st, 2017 - Volume 74 - Issue 3 - p 250–257
doi: 10.1097/QAI.0000000000001244

Introduction: HIV-1 is transmitted through semen from men to their sexual partners. Genital infections can increase HIV-1 RNA shedding in semen, but shedding also occurs in the absence of typical pathogens. We hypothesized that higher bacterial concentrations in semen would be associated with higher HIV-1 RNA levels.

Methods: We analyzed semen samples from 42 HIV-1–seropositive Kenyan men using quantitative polymerase chain reaction (PCR) to assess bacterial concentrations and real-time PCR to measure HIV-1 RNA levels. Generalized estimation equations were used to evaluate associations between these 2 measures. Broad-range 16S rRNA gene PCR with pyrosequencing was performed on a subset of 13 samples to assess bacterial community composition.

Results: Bacteria were detected in 96.6% of 88 samples by quantitative PCR. Semen bacterial concentration and HIV-1 RNA levels were correlated 0.30 (P = 0.01). The association between bacterial concentration and HIV-1 RNA detection was not significant after adjustment for antiretroviral therapy (ART) (adjusted odds ratio: 1.27, 95% CI: 0.84 to 1.91). Factors associated with semen bacterial concentration included insertive anal sex (adjusted beta 0.92, 95% CI: 0.12 to 1.73) and ART use (adjusted beta: −0.77, 95% CI: −1.50 to 0.04). Among 13 samples with pyrosequencing data, Corynebacterium spp., Staphylococcus spp., and Streptococcus spp. were most frequently detected.

Conclusion: Most of these HIV-1–infected men had bacteria in their semen. ART use was associated with undetectable semen HIV-1 RNA and lower semen bacterial concentrations, whereas insertive anal sex was associated with higher bacterial concentrations. Additional studies evaluating the relationship between semen bacteria, inflammation, mucosal immunity, and HIV-1 shedding are needed to understand implications for HIV-1 transmission.

Supplemental Digital Content is Available in the Text.

*Department of Epidemiology, University of Washington, Seattle, WA;

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, WA;

School of Medicine, University of Washington, Seattle, WA;

§Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;

Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya;

Departments of Urology;


**Laboratory Medicine;

††Microbiology; and

‡‡Global Health, University of Washington, Seattle, WA; and

§§University of Nairobi, Nairobi, Kenya.

Correspondence to: Christine J. Korhonen, MPH, Department of Epidemiology, 1959 NE Pacific Street, Health Sciences Building, F-262, University of Washington, Box 357236, Seattle, WA,98195 (e-mail:

Supported by Grant UL1RR025014 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR, NIH, or the Institute of Translational Health Sciences. Information on NCRR is available at Information on Re-engineering the Clinical Research Enterprise can be obtained from This study was also supported by NIH Grants R21 HD055864 and K23 AI69990 (S.M.G.). Additional support was received from the University of Washington Center for AIDS Research, a National Institutes of Health (NIH)-funded programme (P30-AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM). The KEMRI-Wellcome Trust Research Programme at the Centre for Geographic Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (Number 077092).

The authors have no conflicts of interest to disclose.

C.K. and S.S. contributed equally to the manuscript.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received July 05, 2016

Accepted October 28, 2016

Back to Top | Article Outline


HIV-1–infected men transmit HIV-1 through semen to their sexual partners.1 As the level of HIV-1 RNA in semen increases, the risk of transmitting HIV-1 increases.2 Urethritis has been demonstrated to increase semen HIV-1 RNA shedding, even among asymptomatic men and men taking antiretroviral therapy (ART).3,4 In the absence of classical sexually transmitted infections (STIs), HIV-positive men taking ART may still have detectible semen HIV-1 RNA.5 The semen microbiota contains a variety of bacteria in addition to classical STI pathogens6–8 including fastidious bacteria which can be identified and quantified using 16S rRNA gene polymerase chain reaction (PCR) assays.9 A better understanding of factors which increase HIV-1 RNA shedding in semen could result in interventions that reduce HIV-1 transmission from men to their sexual partners.

The goal of this study was to determine the association of semen bacterial concentrations with semen HIV-1 RNA levels in a cohort of HIV-1–positive Kenyan men. We hypothesized that higher semen bacterial concentrations would be associated with higher semen HIV-1 RNA levels. Secondary goals were to determine factors associated with higher semen bacterial concentrations in this population and to identify the bacterial species most commonly found in these samples.

Back to Top | Article Outline


Study Population and Sample Collection

HIV-1–seropositive Kenyan men were recruited from a high-risk cohort including men with multiple sexual partners and men who had sex with men and enrolled between February 2005 and January 2008 into a prospective parent study assessing: (1) postprostatic massage fluid/urine compared with semen for evaluation of male genitourinary HIV-1 shedding,10 and (2) changes in seminal HIV-1 RNA shedding after ART initiation.11 Men were eligible if they were willing to attend up to 5 quarterly study visits; provide blood, urine, and semen samples; and observe 48 hours of sexual abstinence before each semen collection. At each study visit, participants were interviewed about their recent sexual history, number of male and female sexual partners, and health status. Subjects underwent a standardized examination including collection of urine and postprostatic massage fluid/urine to evaluate genital infections and inflammation.10 One week later, semen samples were collected either in the clinic or in participants' homes, with ejaculation into a sterile urine specimen cup or nonreactive condom supplied for this purpose (Durex Avanti; SSL International, Anderson, South California). Participants were asked to submit specimens within 2 hours of ejaculation. Samples with adequate semen quantity remaining after planned study analyses were included in this exploratory study.

Back to Top | Article Outline

Ethics Statement

All participants provided written informed consent. This study was approved by the Kenya Medical Research Institute, the University of Washington, and the Fred Hutchinson Cancer Research Center.

Back to Top | Article Outline

Laboratory Methods

Semen samples received by the laboratory were processed immediately after submission. After volume, appearance, and degree of liquefaction were noted, specimens were warmed in an incubator until liquefaction was complete. Sample aliquots were stored at −70°C until shipment to Seattle for further testing. Semen processing procedures were developed by a qualified andrologist (CHM), with quality assurance by the University of Washington Male Fertility Laboratory.

HIV-1 RNA was quantified in the University of Washington Retrovirology Laboratory. Vials were thawed and microcentrifuged at 16,000g for 15 minutes to separate seminal plasma and cell components. Seminal plasma aliquots (250 mL) were diluted 1:5 with Roswell Park Memorial Institute media,12 and centrifuged for 1 hour at 23,000g. Pellets were resuspended in bioMerieux lysis buffer and extracted using the MiniMAG Extraction system, which employs magnetic silica beads based on the Boom Technology (bioMerieux, Durham, NC).13 HIV-1 RNA was then quantified in seminal plasma using an independently validated TaqMan real-time RNA PCR (RT-PCR) amplification assay or the Amplicor HIV Monitor assay (Roche Molecular Systems, Pleasanton, CA).13 The lower limit for HIV-1 RNA detection was 150 copies per milliliter in plasma and in semen.

Blood CD4 cell counts were determined on-site using an automated method (FACS Count; Becton Dickinson, Forest Lakes, NJ). Additional screening included Trichomonas vaginalis culture (in-Pouch TV; BioMed Diagnostics, White City, OR), Chlamydia trachomatis and Neisseria gonorrhoeae testing (Aptima GC/CT Detection System; Hologic/GenProbe, San Diego, CA), and syphilis testing (rapid plasma reagin confirmed by Treponema pallidum hemagglutination assay).

Bacterial DNA was extracted from 100 μL of semen using the Bacteremia DNA Extraction Kit (Mobio, Carlsbad, CA). Bacterial concentrations were measured using broad-range quantitative PCR (qPCR) amplification of the 16S rRNA gene,14 and PCR inhibition was monitored using an amplification control.15 Species-specific qPCR assays were used to detect bacteria known to colonize the genitalia, including Atopobium vaginae, Gardnerella vaginalis, Leptotrichia/Sneathia spp., Megasphaera spp. types 1 and 2, bacterial vaginosis–associated bacterium (BVAB) 1 and 2, and Mageeibacillus indolicus (BVAB3).16

Broad-range 16S rRNA gene PCR targeting the V3–V4 region of the 16S rRNA gene was used to generate ∼470 bp amplicons, followed by pyrosequencing using the 454 Life Sciences Titanium technology (Roche, Branford, CT) to assess semen microbiota in a subset of samples. There were 13 samples from men not taking ART, with sufficient sample volume and bacterial DNA for this analysis.14,17 Six base-pair barcodes were used to multiplex the samples (see Supplemental Digital Content 1, for barcode sequences), and sequencing was performed from the V2 end of the 16S rRNA gene. Negative controls included sham digests which were processed in the same way as samples to assess contamination from DNA extraction or PCR reagents. We generated 38,159 reads with an average of ∼2900 reads/samples after filtering for length (minimum 250 bp), quality score (minimum 30), and removal of sequence reads originating from contaminants in PCR controls. Sequence reads were classified using the pplacer phylogenetic placement tool,18 with a curated reference set of urogenital bacteria.14 Query sequences were aligned and placed on a phylogenetic tree of reference sequences using pplacer, which finds the optimal insertion of reads on the tree according to maximum-likelihood or Bayesian posterior probability criteria. pplacer infers taxonomic classifications of sequence reads by associating edges of the phylogenetic tree with taxonomic labels. If a specific taxonomic rank is well represented in the phylogenetic tree, the query reads are classified at the species level. However, if there are novel sequences, or heterogeneity in the reads, the query reads are placed at higher taxonomic levels such as genus or family.14 Read sequences have been deposited to the NCBI Short Read Archive (SRP073630). Leukocytes were assessed by differential counting of cells in Wright–Giemsa–stained semen smears for the subset of samples undergoing broad-range PCR with pyrosequencing.

Back to Top | Article Outline

Statistical Analyses

Only visits with data for both semen HIV-1 RNA and bacterial concentrations available were included for analysis. Chronic prostatitis score was determined using the National Institutes of Health Chronic Prostatitis Symptom Index.19 Missing laboratory results were carried forward from the last visit (7 CD4 counts) or imputed as negative when flanking visits were also negative (9 STI screening tests). Bacterial concentrations and HIV-1 RNA levels were log10 transformed.

Spearman rank correlation coefficient was used to test whether log10-transformed semen HIV-1 RNA or CD4 counts were associated with log10-transformed semen bacterial concentrations. Because over half the semen HIV-1 RNA levels were below the level of detection, semen HIV-1 RNA data were classified as undetectable if below the limit of detection (ie, <150 copies/mL). Generalized estimation equations (GEEs) with a logit link and exchangeable correlation matrix were used to assess associations between study variables and detectible semen HIV-1 RNA. GEEs with an identity link and exchangeable correlation matrix were used to assess associations between study variables and log10-transformed semen bacterial concentrations. Data were analyzed using Stata version 13.1 (StataCorp, College Station, TX).

For the analysis of semen bacterial concentration, using a minimum of 1 visit per subject, a sample size of 40 subjects would have 80% power to detect a mean difference in bacterial concentration of 1.3 log10 copies/100 μL between subjects with and without detectible HIV-1 RNA at the α = 0.05 level. With 2 visits per subject, using an exchangeable correlation matrix, this same sample size would have 80% power to detect a mean difference of 1.1 log10 copies/100 μL.20

Back to Top | Article Outline


Study Participants and Samples

Forty-two HIV-1–seropositive men enrolled between February 2005 and January 2008 had adequate semen samples for analysis (Table 1); this excludes 10 men from the original study with inadequate sample volumes. Men were similar to the original study population in participant characteristics (data not shown). The 42 participants contributed samples on 88 visits, with up to 3 visits per subject. Eleven of the 88 samples were collected off-site. For these samples, the average length of time from sample collection to receipt at laboratory was 52 minutes (range 18–120 minutes). Participants were taking ART during 34 visits (38.6%). Twenty-nine (85.3%) of 34 samples from men on ART had no detectable HIV-1 RNA.



Back to Top | Article Outline

Semen Bacteria and HIV-1 RNA

Bacteria were detected in 85 (96.6%) of 88 semen samples. Median bacterial concentrations were 5.2 log10 copies/100 μL (interquartile range, 4.5–5.9 log10 copies/100 μL). HIV-1 RNA was detected in 40 samples (45.5%). Among the 40 samples with detectable levels, the median HIV-1 RNA level was 3.4 log10 copies/mL (interquartile range, 2.5–3.8 log10 copies/mL). Spearman rank correlation coefficient for semen bacteria and HIV-1 RNA level was 0.30 (P = 0.01), whereas the rank correlation coefficient for semen bacteria and CD4 count was 0.01 (P = 0.90). Figure 1A presents semen bacterial concentrations and semen HIV-1 RNA levels. Figure 1B presents semen bacterial concentrations versus CD4 counts. In both figures, the ART status of the patient is indicated. When the sample was restricted to men not taking ART (N = 34 samples), the correlation coefficient for semen bacteria and HIV-1 RNA level was 0.22 (P = 0.11).



Back to Top | Article Outline

Associations With Detectable Semen HIV-1 RNA

In bivariable analyses, semen bacterial concentration [odds ratio (OR) 1.49, 95% CI: 1.26 to 2.15] and ART (OR 0.09, 95% CI: 0.03 to 0.32) were both associated with detectible semen HIV-1 RNA. In the multivariable GEE model, only ART use was associated with detectible semen HIV-1 RNA (adjusted OR 0.11, 95% CI: 0.03 to 0.28, Table 2). In a model restricted to men not taking ART, no association was found between detectible semen HIV-1 RNA and semen bacterial concentration (OR 1.27, 95% CI: 0.78 to 2.08).



Back to Top | Article Outline

Associations With Semen Bacterial Concentration

In bivariable analyses, detectible semen HIV-1 RNA was associated with higher semen bacterial concentration (beta 0.71 log10 copies/100 μL, 95% CI: 0.12 to 1.30 log10 copies/100 μL), whereas ART use was associated with lower bacterial concentration (beta −0.98 log10 copies/100 μL, 95% CI: −1.64 to −0.32 log10 copies/100 μL). In the multivariable GEE model, ART use was associated with lower semen bacterial concentration (adjusted beta −0.77 log10 copies/100 μL, 95% CI: −1.50 to −0.04 log10 copies/100 μL), and insertive anal sex was associated with higher semen bacterial concentration (adjusted beta 0.92 log10 copies/100 μL, 95% CI: 0.12 to 1.73 log10 copies/100 μL, Table 3).



Back to Top | Article Outline

Identification of Targeted Bacteria

Species-specific qPCR was performed on all 88 samples, and 17 (19.3%) were positive in at least 1 assay (Table 4). Among the 44 specimens from men who reported having female sexual partners in the period before sample collection, targeted bacteria were identified in 10 samples (22.7%). Among the 13 specimens from men reporting insertive anal sex, targeted bacteria were identified in 6 samples (46.2%). Leptotrichia/Sneathia spp. were the most commonly detected. Leptotrichia/Sneathia spp. were not associated with HIV-1 RNA shedding in this small sample (χ2 = 0.08, P = 0.8).



Back to Top | Article Outline

Bacterial Communities

Although bacteria were detected in 96.6% of semen samples using qPCR, targeted bacteria were detected in only 19.3% of samples. This suggests that the bacteria present were comprised mainly of species not specifically targeted using the taxon-directed qPCR assays. We applied broad-range PCR with pyrosequencing to a subset of samples from men not taking ART, with sufficient sample volume and bacterial DNA concentration (n = 13) for analysis. Six of the 13 had detectible HIV-1 RNA (Table 1).

Broad-range PCR using primers targeting conserved regions of the 16S rRNA gene, with amplification of the intervening hypervariable region, does not require any a priori information about the bacterial community and can detect most bacteria. Using this approach, we found that all 13 samples contained Corynebacterium spp. ranging in relative abundance from 0.9% to 69%, with 6 samples having a bacterial community dominated by Corynebacterium spp. (≥50% relative abundance, Fig. 2. See Supplemental Digital Content 2, for complete listing). Other common skin bacteria, such as Streptococcus spp. and Staphylococcus spp., were detected in 12 and 13 samples, respectively, with 1 sample being dominated by streptococci (57% relative abundance). One sample was dominated by Bacillus cereus with a relative abundance of 81%. Vaginal bacteria were detected in ≥75% of samples and at a relative abundance ≥5% in at least 1 sample included Prevotella, Porphyromonas, and Anaerococcus spp. Other bacteria meeting the same metrics include Brevibacterium massiliense, Fenollaria massiliensis, and members of the Rhodobacteraceae. We detected G. vaginalis in only 3 samples with a maximum relative abundance of 31%. Leptotrichia species were detected in 5 samples, and A. vaginae in 2 samples at <2% relative abundance. BVAB1, BVAB2, M. indolicus (BVAB3), and Megasphaera spp. types 1 and 2 were not detected in any samples, consistent with the species-specific qPCR data. Escherichia coli sequences were detected in 6 samples by pyrosequencing at low relative abundance (0.02%–0.17% of sequence reads).



Back to Top | Article Outline


The primary objective of this study was to evaluate the association between semen bacterial concentrations and semen HIV-1 RNA levels. Using bacterial 16S rRNA gene qPCR, we detected bacteria in most semen samples (96.6%). Overall, bacterial concentrations and semen HIV-1 RNA levels were correlated, but no association was found in the adjusted analysis. A recent study of the semen microbiome in HIV-infected men also reported correlation between semen bacterial concentrations and HIV-1 RNA levels before ART initiation, and hypothesized that semen bacteria may increase inflammation, HIV shedding, and transmission.8

One secondary goal of this study was to determine factors associated with higher semen bacterial concentrations. Overall, men taking ART had lower bacterial concentrations than those not taking ART. Men who reported insertive anal intercourse had higher semen bacterial concentrations. To our knowledge, this is the first time this association has been reported. One earlier study did find that men who had engaged in significantly higher rates of unprotected intercourse as the insertive partner in the previous 3 months had higher semen viral loads relative to their plasma viral loads.21 It seems plausible that insertive anal sex introduces bacteria from the anal cavity into the male genitourinary tract and semen, which might lead to inflammation and increased semen HIV-1 RNA levels.

Semen specimens were tested for bacteria hypothesized to be associated with insertive vaginal or anal sex; these same bacteria are also associated with bacterial vaginosis, a condition affecting 40%–50% of women in sub-Saharan Africa.22,23 Leptotrichia/Sneathia spp. were detected in 13% of samples and were more common in samples from men reporting insertive anal sex. Leptotrichia/Sneathia spp. have been associated with nonchlamydial nongonococcal urethritis in men24 and can be found in the vagina25 and the anal cavity.26 Leptotrichia/Sneathia spp. have been associated with increased HIV-1 RNA shedding in women on ART.27 It seems plausible that insertive anal sex may introduce bacteria from the anal cavity into the male genitourinary tract, leading to inflammation and increased semen HIV-1 RNA levels. Future studies should investigate the specific bacteria present in semen among men who engage in insertive anal intercourse.

Broad-range PCR with deep sequencing was applied to a subset of samples with sufficient DNA available. The sequence data were processed using our bioinformatics pipeline, which can classify sequences to the species level, facilitating identification of bacteria not reported in other semen microbiota studies, such as B. massiliense (prevalence, 92%) and F. massiliensis (prevalence, 77%). It is unlikely that these sequences are contaminants, as we included buffer and water controls when performing PCR amplification and sequencing. B. massiliense was first isolated from human ankle discharge,28 and F. massiliensis is a recently described isolate from a human osteoarticular sample.29 The most common bacteria detected included skin bacteria, such as Corynebacterium, Staphylococcus, Streptococcus, and Dermabacter species, consistent with published studies of the semen microbiota using cultivation and molecular approaches.6,8,30 As in these studies, we detected bacteria typically present in the vagina, such as G. vaginalis, Prevotella, Peptoniphilus, Porphyromonas, and Anaerococcus species, among others.6,8,30 Lactobacillus crispatus and Lactobacillus iners were detected, but were minority members of the community. Bacillus cereus, a recognized human pathogen which has been noted in nongastrointestinal tract infections and food poisoning,31 was dominant in 1 sample. Mycoplasma spp. and Ureaplasma spp., found in up to 19% of men seeking fertility treatment,8,32,33 and up to 33% of men suspected of urogenital tract infection,34 were relatively uncommon in our samples. Mycoplasma hominis was detected in 2 men (15%), whereas Ureaplasma was not detected (Supplemental Digital Content, Table 2, Bacteria typically present in the gut, such as E. coli, Faecalibacterium prausnitzii, and Eubacterium rectale were minority members of the semen microbiota, suggesting that, in general, semen bacteria are more similar to bacteria on skin and in the vagina, rather than in the gut, an observation made in other studies.8,30

Overall, these data largely agree with other reports of the semen microbiota.8 However, our classification pipeline offers greater granularity of bacterial species present. A key limitation is the small number of samples with sequence data due to relatively low bacterial concentrations. Future studies with a greater number of samples and with higher quantities of semen for DNA extraction will allow greater understanding of the role of the semen microbiota in HIV-1 shedding and transmission.

There are several limitations to this study. Because of the small sample size, power to detect differences was limited. Sample collection followed a detailed protocol, but some skin bacteria found in samples may have resulted from contamination by hand or penile skin flora. Because of limited sample volume, we were unable to identify other potential causes of increased semen HIV-1 RNA levels, such as cytomegalovirus shedding.35,36 Finally, this study took place among HIV-positive Kenyan men and may not be generalizable to other populations or locations. Strengths of the study include the successful collection of hard-to-obtain semen samples. Samples were processed by experienced researchers according to established methods.11 Finally, detailed bacterial testing was performed using state-of-the-art molecular methods.37

We found in this study that ART use was associated with lower semen bacterial concentrations and undetectable semen HIV-1 RNA. Untreated men had higher bacterial concentrations than treated men, possibly because of immunodeficiency. Men reporting insertive anal intercourse had higher bacterial concentrations than those who did not report this behavior. Additional studies are needed to determine the relationship between semen bacteria, inflammation, mucosal immunity, and HIV-1 shedding to understand the implication for HIV-1 transmission.

Back to Top | Article Outline


The authors thank the research staff in Kenya for their dedication, the Kenya Medical Research Institute (KEMRI) and the International AIDS Vaccine Initiative (IAVI) for provision of clinic and laboratory space; Coast Provincial General Hospital for provision of laboratory space; and IAVI for additional support. They thank Kelly Ramko and John Mwambi for laboratory processing of samples in Kenya. They also thank the Director of KEMRI for permission to publish this research. The authors are indebted to the men who participated in this study.

Back to Top | Article Outline


1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8:447–457.
2. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3:77ra29.
3. Winter AJ, Taylor S, Workman J, et al. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sex Transm Infect. 1999;75:261–263.
4. Sadiq ST, Taylor S, Kaye S, et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS. 2002;16:219–225.
5. Sheth PM, Yi TJ, Kovacs C, et al. Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy. Mucosal Immunol. 2012;5:248–257.
6. Hou D, Zhou X, Zhong X, et al. Microbiota of the seminal fluid from healthy and infertile men. Fertil Steril. 2013;100:1261–1269.
7. Kiessling AA, Desmarais BM, Yin HZ, et al. Detection and identification of bacterial DNA in semen. Fertil Steril. 2008;90:1744–1756.
8. Liu CM, Osborne BJW, Hungate BA, et al. The semen microbiome and its relationship with local immunology and viral load in HIV infection. Plos Pathog. 2014;10:e1004262.
9. Lacroix JM, Jarvi K, Batra SD, et al. PCR-based technique for the detection of bacteria in semen and urine. J Microbiol Methods. 1996;26:61–71.
10. Graham SM, Krieger JN, Githua PLM, et al. Post-prostatic massage fluid/urine as an alternative to semen for studying male genitourinary HIV-1 shedding. Sex Transm Infect. 2011;87:232–237.
11. Graham SM, Holte SE, Dragavon JA, et al. HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy. PLoS One. 2012;7:e43086.
12. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989;321:1626–1631.
13. Zuckerman RA, Lucchetti A, Whittington WLH, et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS. 2009;23:479–483.
14. Srinivasan S, Hoffman NG, Morgan MT, et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One. 2012;7:e37818.
15. Khot PD, Ko DL, Hackman RC, et al. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008;8:73.
16. Fredricks DN, Fiedler TL, Thomas KK, et al. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol. 2009;47:721–726.
17. Srinivasan S, Morgan MT, Fiedler TL, et al. Metabolic signatures of bacterial vaginosis. MBio. 2015;6:e00204–e00215.
18. Matsen FA, Kodner RB, Armbrust EV. pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinformatics. 2010;11:538.
19. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369–375.
20. Liu G, Liang KY. Sample size calculations for studies with correlated observations. Biometrics. 1997;53:937–947.
21. Kalichman SC, Cage M, Barnett T, et al. Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates. AIDS Res Hum Retroviruses. 2001;17:1695–1703.
22. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet. 1999;353:525–535.
23. Bukusi EA, Cohen CR, Meier AS, et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis. 2006;33:361–367.
24. Manhart LE, Khosropour CM, Liu C, et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis. 2013;40:944–949.
25. Gorgos LM, Sycuro LK, Srinivasan S, et al. Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis. Sex Transm Dis. 2015;42:475–481.
26. Marrazzo JM, Fiedler TL, Srinivasan S, et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis. 2012;205:1580–1588.
27. Mitchell C, Balkus JE, Fredricks D, et al. Interaction between Lactobacilli, bacterial vaginosis-associated bacteria, and HIV type 1 RNA and DNA genital shedding in U.S. and Kenyan women. AIDS Res Hum Retroviruses. 2013;29:13–19.
28. Roux V, Raoult D. Brevibacterium massiliense sp. nov., isolated from a human ankle discharge. Int J Syst Evol Microbiol. 2009;59:1960–1964.
29. Pagnier I, Croce O, Robert C, et al. Non-contiguous finished genome sequence and description of Fenollaria massiliensis gen. nov., sp. nov., a new genus of anaerobic bacterium. Stand Genomic Sci. 2014;9:704–717.
30. Hillier SL, Rabe LK, Muller CH, et al. Relationship of bacteriologic characteristics to semen indices in men attending an infertility clinic. Obstet Gynecol. 1990;75:800–804.
31. Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23:382–398.
32. Sanocka-Maciejewska D, Ciupińska M, Kurpisz M. Bacterial infection and semen quality. J Reprod Immunol. 2005;67:51–56.
33. Gdoura R, Kchaou W, Ammar-Keskes L, et al. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl. 2008;29:198–206.
34. Filipiak E, Marchlewska K, Oszukowska E, et al. Presence of aerobic micro-organisms and their influence on basic semen parameters in infertile men. Andrologia. 2015;47:826–831.
35. Gianella S, Smith DM, Vargas MV, et al. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013;57:441–447.
36. Gianella S, Morris SR, Vargas MV, et al. Role of seminal shedding of herpesviruses in HIV type 1 transmission. J Infect Dis. 2013;207:257–261.
37. Fredricks DN, Fiedler TL, Thomas KK, et al. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol. 2007;45:3270–3276.

HIV-1; virus shedding; semen; RNA; viral; microbiota; viral load

Supplemental Digital Content

Back to Top | Article Outline
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.